Hibernaid's Unattributed Round

Hibernaid raised a round of funding on January 10, 2018.

Hibernaid is developing drugs and devices for acute medical indications in high-risk critical care patient populations, as well as unique treatments targeting underserved chronic indications.…

Articles about Hibernaid's Unattributed Round: